Get the Stockscreener App
1.31
6.43%
-0.09
Pre-market:
1.38
0.07
+5.34%
Werewolf Therapeutics Inc stock is traded at $1.31, with a volume of 1.22M.
It is down -6.43% in the last 24 hours and down -33.50% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
See More
Previous Close:
$1.40
Open:
$1.41
24h Volume:
1.22M
Relative Volume:
1.71
Market Cap:
$59.90M
Revenue:
$19.94M
Net Income/Loss:
$-37.37M
P/E Ratio:
-1.2596
EPS:
-1.04
Net Cash Flow:
$-33.38M
1W Performance:
-25.99%
1M Performance:
-33.50%
6M Performance:
+45.18%
1Y Performance:
-48.73%
1-Day Range:
$1.08
$1.4297
1-Week Range:
$1.08
$1.83
52-Week Range:
$0.595
$2.585
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.31 | 64.02M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-24-23 | Initiated | Wedbush | Outperform |
| Jun-06-23 | Resumed | Jefferies | Buy |
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
View All
Werewolf Therapeutics Inc Stock (HOWL) Latest News
Advanced analytics toolkit walkthrough for Werewolf Therapeutics Inc.Portfolio Update Summary & Entry Point Strategy Guides - newser.com
Will Werewolf Therapeutics Inc. stock recover faster than market2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Will Werewolf Therapeutics Inc. price bounce be sustainable2025 Top Decliners & Entry Point Confirmation Alerts - newser.com
Werewolf Therapeutics Inc. stock trendline breakdownJuly 2025 Retail & Technical Pattern Alert System - newser.com
Visual trend scoring systems applied to Werewolf Therapeutics Inc.Quarterly Profit Review & Community Verified Swing Trade Signals - newser.com
Is Werewolf Therapeutics Inc. stock bottoming outPortfolio Update Summary & Capital Efficiency Focused Strategies - newser.com
What MACD signals say about Werewolf Therapeutics Inc.2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
Will Werewolf Therapeutics Inc. stock outperform growth indexesForecast Cut & AI Forecast Swing Trade Picks - newser.com
Werewolf Therapeutics Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Analyzing recovery setups for Werewolf Therapeutics Inc. investorsQuarterly Earnings Summary & Real-Time Volume Surge Alerts - newser.com
Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Identifying reversal signals in Werewolf Therapeutics Inc.2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is Werewolf Therapeutics Inc. reversing from oversold territoryBuy Signal & Expert Approved Trade Ideas - newser.com
Will Werewolf Therapeutics Inc. stock reach all time highs in 2025Weekly Profit Analysis & Weekly High Return Forecasts - newser.com
Bioventures 2014 L.P. Mpm Sells 134,240 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Luke Evnin Sells 44,327 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Luke Evnin Sells 46,664 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
How to read the order book for Werewolf Therapeutics Inc.CPI Data & Comprehensive Market Scan Insights - newser.com
Why analysts remain bullish on Werewolf Therapeutics Inc. stockJuly 2025 Highlights & Reliable Volume Spike Alerts - fcp.pa.gov.br
US Market Recap: Will Werewolf Therapeutics Inc. stock recover faster than marketJuly 2025 Price Swings & Precise Buy Zone Identification - Fundação Cultural do Pará
Werewolf Therapeutics’ WTX-330 Study: A Potential Game-Changer in Oncology - TipRanks
Werewolf Therapeutics’ Promising Study on WTX-124 in Cancer Treatment - TipRanks
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):